Aristotle Capital Management LLC lessened its stake in shares of Xylem Inc. (NYSE:XYL – Free Report) by 44.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,231 shares of the industrial products company’s stock after selling 11,198 shares during the period. Aristotle Capital Management LLC’s holdings in Xylem were worth $1,701,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. J. Stern & Co. LLP raised its stake in Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after acquiring an additional 45,082,435 shares during the last quarter. Norges Bank purchased a new stake in Xylem during the 4th quarter valued at about $361,012,000. SEB Asset Management AB purchased a new position in shares of Xylem in the first quarter worth about $66,700,000. Balyasny Asset Management L.P. lifted its holdings in shares of Xylem by 346.2% during the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock worth $105,160,000 after purchasing an additional 553,152 shares during the period. Finally, Adage Capital Partners GP L.L.C. acquired a new stake in shares of Xylem during the second quarter worth about $64,407,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Stock Up 2.4%
NYSE:XYL opened at $119.66 on Friday. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The stock’s fifty day moving average is $114.04 and its two-hundred day moving average is $122.82. The stock has a market capitalization of $28.44 billion, a price-to-earnings ratio of 29.77, a price-to-earnings-growth ratio of 1.66 and a beta of 1.03. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13.
Xylem Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were paid a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. Xylem’s dividend payout ratio (DPR) is presently 42.79%.
Wall Street Analysts Forecast Growth
XYL has been the topic of a number of research reports. Citigroup cut their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and upped their target price for the stock from $130.00 to $140.00 in a research note on Thursday, June 25th. Stifel Nicolaus dropped their target price on Xylem from $159.00 to $157.00 and set a “buy” rating on the stock in a report on Monday. UBS Group boosted their price target on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Finally, CLSA raised shares of Xylem to a “hold” rating in a research note on Thursday, June 25th. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, Xylem currently has an average rating of “Moderate Buy” and an average price target of $153.15.
Get Our Latest Analysis on Xylem
Insider Activity at Xylem
In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of Xylem stock in a transaction dated Monday, May 4th. The stock was purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This represents a 4.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.32% of the company’s stock.
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
